{"pub_date": "2016-04-24T04:00:00Z", "subsection_name": "Sunday Review", "lead_paragraph": "That expensive new medication might not work any better than an older, cheaper alternative.", "print_page": "5", "document_type": "article", "byline": {"person": [{"rank": 1, "organization": "", "lastname": "FRIEDMAN", "firstname": "Richard", "role": "reported", "middlename": "A."}], "original": "By RICHARD A. FRIEDMAN"}, "multimedia": [{"width": 190, "height": 126, "url": "images/2016/04/24/sunday-review/24Friedman1/24Friedman1-thumbWide-v2.jpg", "subtype": "wide", "legacy": {"wide": "images/2016/04/24/sunday-review/24Friedman1/24Friedman1-thumbWide-v2.jpg", "widewidth": "190", "wideheight": "126"}, "type": "image"}, {"width": 600, "height": 399, "url": "images/2016/04/24/sunday-review/24Friedman1/24Friedman1-articleLarge-v2.jpg", "subtype": "xlarge", "legacy": {"xlargewidth": "600", "xlargeheight": "399", "xlarge": "images/2016/04/24/sunday-review/24Friedman1/24Friedman1-articleLarge-v2.jpg"}, "type": "image"}, {"width": 75, "height": 75, "url": "images/2016/04/24/sunday-review/24Friedman1/24Friedman1-thumbStandard-v2.jpg", "subtype": "thumbnail", "legacy": {"thumbnail": "images/2016/04/24/sunday-review/24Friedman1/24Friedman1-thumbStandard-v2.jpg", "thumbnailwidth": "75", "thumbnailheight": "75"}, "type": "image"}], "section_name": "Opinion", "headline": {"content_kicker": "Contributing Op-Ed Writer", "print_headline": "What Drug Ads Don\u2019t Say", "main": "What Drug Ads Don\u2019t Say", "kicker": "Op-Ed | Richard A. Friedman"}, "source": "The New York Times", "blog": [], "word_count": "918", "web_url": "http://www.nytimes.com/2016/04/24/opinion/sunday/what-drug-ads-dont-say.html", "slideshow_credits": null, "news_desk": "OpEd", "type_of_material": "Op-Ed", "snippet": "That expensive new medication might not work any better than an older, cheaper alternative.", "_id": "571bbf4138f0d84a765c08e1", "abstract": "Richard A Friedman Op-Ed article argues trend in advertising by pharmaceutical companies, describing all possible side effects of new drugs, lulls even savviest consumer into false sense of security that drugmakers are telling them all they need to know; contends what is missing is information about older, cheaper drugs that are just as safe and effective; suggests universal scorecard for all new medications, overseen by FDA, displaying information on how cost and effectiveness of new drugs measure up against similar medications.", "keywords": [{"rank": "1", "name": "subject", "value": "Advertising and Marketing", "is_major": "Y"}, {"rank": "2", "name": "subject", "value": "Drugs (Pharmaceuticals)", "is_major": "Y"}, {"rank": "3", "name": "subject", "value": "Patient Protection and Affordable Care Act (2010)", "is_major": "N"}, {"rank": "4", "name": "organizations", "value": "Food and Drug Administration", "is_major": "N"}, {"rank": "5", "name": "subject", "value": "Consumer Protection", "is_major": "N"}]}